🩸

Understanding Bleeding and Coagulation Disorders

Apr 30, 2025

Bleeding and Coagulation Disorders

Overview

  • Topics Covered:
    • Hemophilia A
    • Hemophilia B
    • Von Willebrand Disease
    • Factor V Leiden
    • Protein C and S Deficiency
  • Aim: Simplify these disorders by understanding their pathophysiology.

Hemophilia A

  • Type: Most common type of hemophilia; X-linked recessive disorder.
  • Affected Individuals: Primarily affects males (one X chromosome).
  • Mnemonic: Think of "Phil" as in "Dr. Phil", male association.
  • Deficiency: Factor VIII (8) deficiency; intrinsic pathway disruption.
  • Symptoms:
    • Hemarthrosis (bleeding into joint spaces).
    • Swelling out of proportion to injury.
  • Diagnosis:
    • Normal PT, prolonged PTT (measures intrinsic pathway including Factor VIII).
    • Factor VIII assay (can be normal in mild cases).
  • Treatment:
    • Factor VIII infusions.
    • Desmopressin (DDAVP) for mild cases (stimulates von Willebrand factor release).

Hemophilia B

  • Type: Similar to Hemophilia A but less common.
  • Deficiency: Factor IX deficiency; also X-linked recessive.
  • Mnemonic: B9 - "benign tumor" association.
  • Symptoms: Similar to Hemophilia A.
  • Diagnosis:
    • Normal PT, prolonged PTT (measures intrinsic pathway including Factor IX).
    • Factor IX assay.
  • Treatment:
    • Factor IX infusions.
    • Note: DDAVP not used (only effective for Factor VIII).

Von Willebrand Disease

  • Type: Most common inherited bleeding disorder.
  • Deficiency: Decrease in quantity/quality of von Willebrand factor.
  • Symptoms:
    • Mucocutaneous bleeding, easy bruising.
  • Diagnosis:
    • Normal PT, prolonged PTT (due to factor VIII degradation without von Willebrand factor).
    • Von Willebrand factor antigen/activity tests.
    • Ristocetin test (measures platelet aggregation).
  • Treatment:
    • Desmopressin (DDAVP) for mild cases.
    • Von Willebrand factor concentrates for severe cases.

Factor V Leiden

  • Type: Mutation leading to hypercoagulable state.
  • Mutation: Factor V (resistant to inactivation by Protein C).
  • Mnemonic: "Frequently Forming Lumps" (lumps = clots).
  • Symptoms:
    • Venous thromboembolism (DVTs, PEs).
    • Miscarriages.
  • Diagnosis:
    • Genetic testing for point mutation.
    • Initial protein C resistance test.
  • Treatment:
    • Anticoagulation.

Protein C and S Deficiency

  • Type: Decreased levels lead to hypercoagulable state.
  • Function: Protein C and S inactivate Factors V and VIII (prevent excessive clotting).
  • Symptoms:
    • Venous thromboembolism.
    • Warfarin-induced skin necrosis (due to transient hypercoagulable state from warfarin).
  • Diagnosis:
    • Protein C and S assays (measure activity/levels).
  • Treatment:
    • Anticoagulation.
    • Protein C concentrate for prophylaxis in surgeries or pregnancy.

Important Points

  • Hemophilia A: Factor VIII deficiency, male patients, use DDAVP.
  • Hemophilia B: Factor IX deficiency, similar treatment sans DDAVP.
  • Von Willebrand Disease: Most common bleeding disorder, treat with DDAVP.
  • Factor V Leiden: Most common inherited hypercoagulable state, treat with anticoagulation.
  • Protein C and S Deficiency: Leads to hypercoagulability, manage with anticoagulation and protein C concentrates.